Less than half of patients with liver cancer are diagnosed at an early stage, when the 5 - year survival is 31 %. (cancerresearch.org)
The overall 5 - year relative survival rate for patients with liver cancer is 17 %. (cancerresearch.org)
After excluding patients with liver cancer before the follow ‐ up index dates, 1,553 patients who had continuously received daily aspirin for at least 90 days were randomly matched 1:4 with 6,212 patients who had never received anti platelet therapy by means of propensity scores consisting of baseline characteristics, the index date and nucleos (t) ide analogue (NA) use during follow ‐ up. (sciencedaily.com)